William Blair:重申icon(ICLR.US)评级,由优于大市调整至优于大市评级。Icon PLC(ICLR.US)公司简介:Icon PLC是一家全球性的后期合同研究机构,为制药、生物技术和医疗设备公司提供药物开发和临床试验服务。虽然Icon的绝大部分收入来自临床研究,但公司也提供辅助服务,如实验室和成像功能。这家公司的总部设在爱尔兰。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.